Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective

Inflamm Bowel Dis. 2020 Sep 18;26(10):e125-e126. doi: 10.1093/ibd/izaa171.

Authors

Jennie N Clough^{1

2}, Katie L Hill¹, Alexa Duff¹, Esha Sharma³, Shuvra Ray¹, Joel E Mawdsley¹, Simon Anderson¹, Peter M Irving^{1

4}, Mark A Samaan¹

Affiliations

¹ Gastroenterology Department, Guy's and St. Thomas's National Health service (NHS) Foundation Trust, London, United Kingdom.
² National Institute for Health Research Biomedical Research Centre, Guy's Hospital, London, United Kingdom.
³ Pharmacy Department, Guy's and St. Thomas's NHS Foundation Trust, London, United Kingdom.
⁴ School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Gastroenterology*
Humans
Inflammatory Bowel Diseases / epidemiology*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2